Dr. Ramkumar Menon, professor and director of the division of basic and translational research in obstetrics and gynecology at The University of Texas Medical Branch in Galveston and one of two principal investigators at the new March of Dimes Texas Collaborative Prematurity Research Center, discusses his career and focus at the PRC: pregnancy-on-a-chip technology that simulates human pregnancy and will be used to validate drugs that may reverse preterm birth.
All content for MODCAST is the property of March of Dimes and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dr. Ramkumar Menon, professor and director of the division of basic and translational research in obstetrics and gynecology at The University of Texas Medical Branch in Galveston and one of two principal investigators at the new March of Dimes Texas Collaborative Prematurity Research Center, discusses his career and focus at the PRC: pregnancy-on-a-chip technology that simulates human pregnancy and will be used to validate drugs that may reverse preterm birth.
Dr. Sindhu Srinivas and Alexia Doumbouya on a Trial Testing the Impact of Doulas
MODCAST
1 hour 20 minutes
3 months ago
Dr. Sindhu Srinivas and Alexia Doumbouya on a Trial Testing the Impact of Doulas
March of Dimes Research Center for Advancing Maternal Health Equity investigator Dr. Sindhu Srinivas and doula Alexia Doumbouya discuss leading a randomized controlled trial (RCT) on whether doula integration throughout pregnancy, birth, and postpartum can decrease maternal depression and anxiety.
MODCAST
Dr. Ramkumar Menon, professor and director of the division of basic and translational research in obstetrics and gynecology at The University of Texas Medical Branch in Galveston and one of two principal investigators at the new March of Dimes Texas Collaborative Prematurity Research Center, discusses his career and focus at the PRC: pregnancy-on-a-chip technology that simulates human pregnancy and will be used to validate drugs that may reverse preterm birth.
